Search Results 71-80 of 13964 for Moderate acute malnutrition

  1. A Study To Evaluate ALZT-OP1a In Subjects With Mild-to-Moderate Amyotrophic Lateral Sclerosis - Mayo Clinic

    The purposes of this study are to measure the impact of two doses of ALZT-OP1a (cromolyn) on neuro-inflammation by measuring plasma neuroinflammatory biomarkers ...

  2. Acetaminophen (intravenous route) - Side effects & uses - Mayo Clinic

    Description. Acetaminophen injection is used together with other medicines (eg, narcotic pain relievers) to relieve moderate to severe pain.

  3. Rhu-pGSN For Acute Respiratory Distress Syndrome (ARDS) - Mayo Clinic

    The purpose of this study is to evaluate the efficacy and safety of rhu-pGSN plus standard of care (SOC) in subjects with moderate-to-severe ARDS (P/F ratio ≤ ...

  4. Recovery From Cushing Syndrome And Mild Autonomous Cortisol Secretion - Mayo Clinic

    The primary purpose of this study is to determine pre-surgical and post-surgical predictors of the duration and severity of glucocorticoid withdrawal in ...

  5. Treat-to-Target Of Endoscopic Remission In Patients With IBD In Symptomatic Remission - Mayo Clinic

    TIM showing moderate-severe bowel inflammation. Validated PROs are defined as: 1. CD: PRO2 (2-item patient reported outcome) mean daily score of abdominal ...

  6. Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab To IV/SC Ustekinumab To Assess Change In Crohn's Disease Activity Index (CDAI) In Adult Participants With Moderate To Severe Crohn's Disease (CD) - Mayo Clinic

    Ustekinumab is an approved drug for the treatment of moderate and severe CD. Participation eligibility. Participant eligibility includes age, gender, type and ...

  7. Precision Ventilation Vs Standard Care For Acute Respiratory Distress Syndrome - Mayo Clinic

    ... Acute Respiratory Distress Syndrome (ARDS). Participants will be ... Moderate or severe ARDS, defined as meeting all of the following (a-e): 1 ...

  8. Diuretics Alone Vs. Aortix Endovascular Device For Acute Heart Failure - Mayo Clinic

    Aortix is a circulatory support device for chronic heart failure patients on medical management who have been hospitalized for acute decompensated heart ...

  9. A Study Of The Efficacy And Safety Of Upadacitinib (ABT-494) In Subjects With Moderately To Severely Active Crohn's Disease Who Have Inadequately Responded To Or Are Intolerant To Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

    The objective of this study is to evaluate the efficacy and safety of upadacitinib compared to placebo as induction therapy in participants with moderately and ...

  10. Funding - Mayo Clinic Research

    Funding. Research into the pathophysiology of pancreatitis in the Pancreatitis and Acute Outcomes Research Lab at Mayo Clinic is funded by federal grants ...